Core Laboratories N.V. (CLB)
| Market Cap | 1.50B |
| Revenue (ttm) | 443.25M |
| Net Income (ttm) | 18.89M |
| Shares Out | 46.31M |
| EPS (ttm) | 0.42 |
| PE Ratio | 78.42 |
| Forward PE | 38.91 |
| Dividend | $0.04 |
| Dividend Yield | 0.12% |
| Trading Day | May 13 |
| Last Price | $33.17 |
| Previous Close | $33.59 |
| Change ($) | -0.42 |
| Change (%) | -1.25% |
| Day's Open | 33.04 |
| Day's Range | 31.94 - 33.82 |
| Day's Volume | 422,816 |
| 52-Week Range | 13.42 - 41.97 |
In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.
Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Core Laboratories (NYSE:CLB) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 51.61% over the past year to $0.15, which beat t...
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Could oil be the cause?
The energy services company has been caught in the ups and downs of the broader energy sector. Here's why that's par for the course.
AMSTERDAM, March 22, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2...
You can blame oil for most of the drop.
Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call Transcript
Shares took a roller coaster ride today, as the big news was earnings.
In the December quarter, Core Labs (CLB) generates $57.9 million in operating cash and its capital expenditure totals $11.9 million, leading to a $46-million free cash flow (FCF) recognition.
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
It's time to have a bird's-eye view of the upstream oil industry using information gleaned from a variety of industry sources.
On Wednesday, January 27, Core Laboratories (NYSE:CLB) will release its latest earnings report. Here is Benzinga's outlook for the company.
Core Laboratories' (CLB) cost-saving measures are expected to have driven fourth-quarter earnings and cash flows higher.
Cost-cutting measures and demand recovery for oilfield equipment & services have likely aided companies belonging to the oilfield service space in Q4. SLB, BKR & CLB are yet to report earnings.
The energy markets got a shock, and it rippled across the entire industry landscape. There are lessons here.
The oil market got a pleasant surprise.
AMSTERDAM, Dec. 28, 2020 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2020 conference call over the Internet at 7:30 a.m. CST / 2...
The oil and gas services provider is conducting an at-the-market offering to raise capital.
John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed earlier this week his firm upped its stakes in Core Laboratories NV (NYSE:CLB) and Madison Square Garden Entertainment Corp. (NYSE...
Energy stocks from across the spectrum rose along with the key products the sector produces. Here's what you need to know.
Core Laboratories Nv shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Core Laboratories Nv Sees IBD RS Rating Rise To 78 appeared first on Investor's Busin...
Oil prices were lower today, but investors in the energy patch were watching OPEC and not liking what they saw.
Energy services names got a jolt from excited investors after a third vaccine candidate reported impressive results. Here's what you need to know.
Energy services provider Core Labs got a boost from rising oil prices, but it's a tap-on effect from a bigger story unfolding in the news.
There's big news about COVID-19, but it will take some time before this trio sees any benefit. That didn't stop investors.
In the September quarter, Core Labs (CLB) generates $20.7 million in operating cash and its capital expenditure totals $2.2 million, leading to $18.5-million free cash flow (FCF) recognition.
Core Laboratories' (CLB) CEO Larry Bruno on Q3 2020 Results - Earnings Call Transcript
The company continues to generate free cash flow even as the oil industry remains depressed.
Core Laboratories (CLB) delivered earnings and revenue surprises of 14.29% and -3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
On Wednesday, October 21, Core Laboratories (NYSE: CLB) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Core Laboratories' (CLB) Production Enhancement unit is expected to have incurred operating loss in Q3, same as the previous quarter.
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Although the world continues to work its way back from pandemic shutdowns, energy-related stocks are still suffering.
It was just another day of volatility for Core Laboratories. Here's what happened and what you should be thinking now.
Energy services names are getting hit hard by the energy downturn. Should you pick up industry-leading names like Baker Hughes and Core Labs?
Shares of energy-related names didn't fare well, but there are two parts to the story.
A broad collection of energy companies got a boost today, but the rise isn't really all that surprising.
Investors are clearly worried about the future for this energy services company.
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
HAL vs. CLB: Which Stock Is the Better Value Option?
As of late, it has definitely been a great time to be an investor in Core Laboratories N.V. (CLB).
Core Laboratories NV (CLB) CEO Lawrence Bruno on Q2 2020 Results - Earnings Call Transcript
In the June quarter, Core Labs (CLB) generates $27 million in operating cash and its capital expenditure totals $3.1 million, leading to $23.9-million free cash flow (FCF) recognition.
Core Laboratories (CLB) delivered earnings and revenue surprises of 55.56% and 0.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
About CLB
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize pro... [Read more...]
| Industry Oil & Gas Equipment & Services | IPO Date Sep 20, 1995 |
| Stock Exchange NYSE | Ticker Symbol CLB |
Analyst Forecasts
According to 13 analysts, the average rating for CLB stock is "Hold." The 12-month stock price forecast is 29.64, which is a decrease of -10.64% from the latest price.